Trial Frees Type 1 Diabetes Patients From Daily Insulin Jabs
A groundbreaking clinical trial using islet cell transplants and Tegoprubart freed five Type 1 diabetes patients from daily insulin jabs, marking a huge step toward a functional cure.
News That Embraces Insight and Understanding
A groundbreaking clinical trial using islet cell transplants and Tegoprubart freed five Type 1 diabetes patients from daily insulin jabs, marking a huge step toward a functional cure.
At Beijing’s Sanlitun forum, TCM meets AI, mixed reality & robotics, sparking a sustainable, high-tech makeover for ancient Chinese medicine.
Average life expectancy in the Chinese mainland rose to 79 years, backed by rising incomes, expanded pensions and stable jobs under the 14th Five-Year Plan.
At CIFTIS 2025 in Beijing, AI-powered robotic arms are demoing surgeries with next-level precision and safety. Are you ready to trust robots in the OR?
Brazilian scientists have launched a new mosquito breeding facility to tackle a rising tide of mosquito-borne diseases spreading from the Indian Ocean to Asia. Here’s how they’re innovating.
Australia approves the world’s first koala vaccine against chlamydia, marking a major win for wildlife conservation and tech-driven animal health.
US researchers develop MAARS, a new AI model predicting sudden cardiac death at 89% accuracy, marking a leap in heart care.
China’s clinical trial of an invasive BCI marks breakthrough progress in neural tech and offers renewed hope for motor-impaired patients.
China enhances its voluntary blood donation system with advanced screening, rapid supply response, and creative public campaigns that foster a culture of giving.
Tofersen, a groundbreaking gene-targeted ALS drug, launches on the Chinese mainland, offering renewed hope against this fatal disease.